Myriam Y Hsu
Overview
Explore the profile of Myriam Y Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mistretta M, Fiorito V, Allocco A, Ammirata G, Hsu M, Digiovanni S, et al.
Cell Rep
. 2024 Feb;
43(3):113854.
PMID: 38412099
The definition of cell metabolic profile is essential to ensure skeletal muscle fiber heterogeneity and to achieve a proper equilibrium between the self-renewal and commitment of satellite stem cells. Heme...
2.
Mina E, Wyart E, Sartori R, Angelino E, Zaggia I, Rausch V, et al.
Cell Rep Med
. 2023 Dec;
4(12):101306.
PMID: 38052214
Skeletal muscle atrophy is a hallmark of cachexia, a wasting condition typical of chronic pathologies, that still represents an unmet medical need. Bone morphogenetic protein (BMP)-Smad1/5/8 signaling alterations are emerging...
3.
Beltra M, Pollanen N, Fornelli C, Tonttila K, Hsu M, Zampieri S, et al.
Nat Commun
. 2023 Apr;
14(1):1849.
PMID: 37012289
Cachexia is a debilitating wasting syndrome and highly prevalent comorbidity in cancer patients. It manifests especially with energy and mitochondrial metabolism aberrations that promote tissue wasting. We recently identified nicotinamide...
4.
Wyart E, Hsu M, Sartori R, Mina E, Rausch V, Pierobon E, et al.
EMBO Rep
. 2022 Feb;
23(4):e53746.
PMID: 35199910
Cachexia is a wasting syndrome characterized by devastating skeletal muscle atrophy that dramatically increases mortality in various diseases, most notably in cancer patients with a penetrance of up to 80%....
5.
Li H, Prever L, Hsu M, Lo W, Margaria J, De Santis M, et al.
Adv Sci (Weinh)
. 2022 Jan;
9(9):e2103249.
PMID: 35098698
Breast cancer is the most prevalent cancer and a major cause of death in women worldwide. Although early diagnosis and therapeutic intervention significantly improve patient survival rate, metastasis still accounts...
6.
Hsu M, Mina E, Roetto A, Porporato P
Cells
. 2020 Dec;
9(12).
PMID: 33287315
Cancer cells undergo considerable metabolic changes to foster uncontrolled proliferation in a hostile environment characterized by nutrient deprivation, poor vascularization and immune infiltration. While metabolic reprogramming has been recognized as...
7.
Anemone A, Consolino L, Conti L, Irrera P, Hsu M, Villano D, et al.
Br J Cancer
. 2020 Dec;
124(1):207-216.
PMID: 33257841
Background: Tumour acidosis is considered to play a central role in promoting cancer invasion and migration, but few studies have investigated in vivo how tumour pH correlates with cancer invasion....
8.
Hsu M, Porporato P, Wyart E
Methods Mol Biol
. 2019 Feb;
1928:337-352.
PMID: 30725463
Cancer cachexia is a metabolic disease characterized by a negative energy balance associated with systemic weight loss and poor quality of life.In particular, skeletal muscle, which represents almost 50% of...
9.
Wyart E, Reano S, Hsu M, Longo D, Li M, Hirsch E, et al.
Oxid Med Cell Longev
. 2018 Apr;
2018:6419805.
PMID: 29682162
Cancer cachexia is a devastating syndrome occurring in the majority of terminally ill cancer patients. Notably, skeletal muscle atrophy is a consistent feature affecting the quality of life and prognosis....
10.
Payen V, Hsu M, Radecke K, Wyart E, Vazeille T, Bouzin C, et al.
Cancer Res
. 2017 Aug;
77(20):5591-5601.
PMID: 28827372
Extracellular acidosis resulting from intense metabolic activities in tumors promotes cancer cell migration, invasion, and metastasis. Although host cells die at low extracellular pH, cancer cells resist, as they are...